U.S. Household Products Stock News

Chord Energy (CHRD) just paired strong second quarter earnings with higher oil production, fresh guidance, and an updated capital return plan, giving you several new data points to weigh the stock. See our latest analysis for Chord Energy. The latest Q2 update, dividend affirmation, and ongoing buybacks have arrived against a strong backdrop for Chord Energy, with the share price up 45.04% year to date, giving back 7.46% over 3 months, and delivering a 5 year total shareholder return of...

Earlier in August 2026, Structure Therapeutics appointed industry veteran John Berrios as Chief Commercial Officer and outlined upcoming aleniglipron trial readouts, while reporting a higher second-quarter net loss of US$106.16 million and basic loss per share of US$1.47 year on year. The combination of a commercially focused leadership hire from Novo Nordisk and detailed timelines for obesity and diabetes trials could influence how investors view Structure Therapeutics’ long-term...

Central Bancompany (CBC) shares are in focus after the company reported second quarter and six month 2026 results, announced a new US$100 million buyback plan, and affirmed its quarterly cash dividend. See our latest analysis for Central Bancompany. Central Bancompany’s share price has pulled back slightly in the past week, yet the 30 day share price return of 4.24% and year to date share price return of 36.98% suggest momentum has been building, reinforced by recent earnings, buyback and...

LandBridge (LB) is drawing attention after its second quarter 2026 earnings, a quarterly dividend declaration, and fresh commentary on an active acquisition pipeline tied to its Delaware Basin surface and infrastructure portfolio. See our latest analysis for LandBridge. LandBridge's recent news on record Q2 2026 results, the ongoing conversion to a Texas corporation, and an active M&A pipeline comes alongside strong share price momentum, with a year to date share price return of 62.38% and a...

Digital Turbine, Inc. reported past first-quarter 2026 results with sales of US$165.98 million versus US$130.93 million a year earlier, while trimming its net loss to US$3.16 million from US$14.10 million and reducing basic and diluted loss per share from US$0.13 to US$0.03. The company also raised its revenue guidance for fiscal 2027 to a range of US$650 million to US$670 million, signaling management’s increased confidence in the business following improved quarterly performance. We’ll now...

In the past few days, Rosen Law Firm announced an investigation into potential securities claims against PennyMac Financial Services, following allegations that the company may have provided materially misleading business information amid a significant drop in servicing segment pretax income. This legal scrutiny introduces fresh uncertainty around PennyMac’s past disclosures and risk controls, raising questions about how resilient its business model and reporting practices may be under...

What Enpro’s Updated Outlook Means For Investors Enpro (NPO) raised its 2026 earnings guidance on 4 August 2026, now projecting revenue growth of 14% to 16% compared to 10% to 14% a year ago. This update followed the company’s second quarter earnings release. For investors, the combination of refreshed guidance and recent results provides a clearer snapshot of how Enpro’s current operations in sealing and advanced surface technologies are feeding into near term expectations. See our latest...

In the past quarter, Ardent Health, Inc. reported second-quarter 2026 sales of US$1,622.25 million and net income of US$16.9 million, alongside lower full-year 2026 earnings guidance and updated expectations for total revenue between US$6.40 billion and US$6.70 billion. Despite softer earnings and trimmed guidance, Ardent continued repurchasing shares under its existing buyback and drew heightened attention in the options market, where elevated implied volatility on certain contracts...

Establishment Labs Holdings (ESTA) drew investor attention after reporting second quarter 2026 results with higher sales and a smaller net loss than a year earlier, along with slightly raised full year revenue guidance. See our latest analysis for Establishment Labs Holdings. At a share price of $79.47, Establishment Labs Holdings has a 1 day share price return of 5.13% and a 90 day share price return of 20.85%, while the 1 year total shareholder return of 107.39% points to strong momentum...

In August 2026, Sharplink, Inc. reported second-quarter revenue of US$11.53 million and a net loss of about US$394.27 million, while separately committing US$200 million of its Ethereum treasury to Lido’s liquid staking protocol and launching the Galaxy Sharplink Onchain Yield Fund, LP with US$125 million in capital. Together, these moves highlight Sharplink’s effort to turn a large ETH treasury into a more productive, institutionally managed onchain portfolio despite ongoing losses. We’ll...

International Bancshares earnings and dividend move draw investor focus International Bancshares (IBOC) is back in the spotlight after reporting second quarter 2026 results that showed higher net interest income but slightly softer net income, alongside a newly declared cash dividend of $0.73 per share. See our latest analysis for International Bancshares. International Bancshares shares have eased over the past month with a 30 day share price return of 2.96% lower. However, the year to date...

Match Group (MTCH) has been active this week, pairing a new US$257.75 million shelf registration for 6,250,000 ESOP related common shares with a fresh quarterly dividend, as well as recent earnings and buyback updates. See our latest analysis for Match Group. Match Group’s recent shelf registration, dividend announcement, earnings update and buyback completion have played out against a share price of US$37.95, with a 19.57% year to date share price return but a much weaker 5 year total...

In early August 2026, TransMedics Group reported second-quarter revenue of US$189.95 million and net income of US$14.68 million, with lower earnings per share than the same period a year earlier. Despite profit compression, the company raised the low end of its full-year 2026 revenue guidance to a range of US$737 million to US$757 million, signaling confidence in its top-line trajectory. Next, we’ll examine how the raised full-year revenue guidance reshapes TransMedics’ existing investment...

In August 2026, OPENLANE, Inc. completed a follow-on equity offering of 8,000,000 common shares at US$34.36 each, raising about US$274.88 million, following a period of higher 2026 net income guidance and stronger second-quarter earnings. This capital raise, coming soon after the company finished a US$98.74 million share repurchase program, highlights a rapid shift in capital allocation priorities and potential plans for funding future growth or balance sheet flexibility. We’ll now examine...

Sotera Health reported its second-quarter 2026 results, with revenue rising to US$321.38 million from US$294.34 million and net income increasing to US$53.64 million from US$7.96 million a year earlier, while earnings also improved sharply for the first half of the year. Beyond the headline growth, the company’s broad-based strength across Sterigenics, Nordion, and Nelson Labs, together with a raised full-year outlook, underlines how new capacity, pricing, and operational efficiencies are...

Schneider National (SNDR) moved into focus after its second quarter 2026 earnings report, which showed higher sales, increased net income and earnings per share, alongside a top Zacks Rank and progress on operational improvements. See our latest analysis for Schneider National. At a share price of US$36.10, Schneider National has seen solid momentum this year, with a year to date share price return of 33.85% and a 1 year total shareholder return of 49.76%. The 90 day share price return of...

Dave Inc. recently reported past second-quarter 2026 results, with revenue rising to US$170.79 million from US$131.76 million a year earlier, while quarterly net income eased to US$6.69 million and diluted earnings per share from continuing operations moved to US$0.49 from US$0.62. Over the first half of 2026, Dave’s revenue climbed to US$329.21 million and net income to US$64.62 million, and the company reinforced its confidence by lifting full-year 2026 GAAP operating revenue guidance to...

Aeva Technologies has launched an Optical Connectivity business aimed at bringing its high-power optical source and silicon photonics technology into next-generation artificial intelligence data centers, alongside reporting second-quarter 2026 revenue of US$6.14 million and a net loss of US$79.62 million, and announcing an upcoming CFO transition effective September 5, 2026. The new Optical Connectivity unit, backed by a joint development agreement with a high-speed optical engine provider...

Nelnet, Inc. previously reported second-quarter 2026 net income of US$66.66 million, with basic earnings per share from continuing operations of US$1.85, down from US$181.46 million and US$4.97 a year earlier, while also declaring a third-quarter dividend of US$0.33 per share and completing a share repurchase program totaling 780,761 shares. The combination of weaker year-on-year earnings, continued dividend payments, and completion of the previously announced buyback gives a mixed signal...

Revenue Beat Puts First Bancorp (FBNC) Earnings in Focus First Bancorp (FBNC) recently reported quarterly revenue of $127.8 million, reflecting 30.9% year on year growth and coming in 1.4% above analyst expectations. This result has helped draw fresh attention to the stock. The report also included a narrow beat on net interest income estimates and a slight miss on tangible book value per share. Since the release, First Bancorp's share price has risen 4.2% to $65.21 as of the latest...

On August 5, 2026, Regency Centers Corporation declared past quarterly cash dividends of US$0.755 per common share and US$0.390625 and US$0.367200 per Series A and Series B preferred share, respectively, with payments scheduled in October 2026 to shareholders of record in September and October. These dividend declarations, alongside previously reported strong Q2 leasing and raised full-year Nareit FFO and same-property NOI guidance, underscore Regency Centers’ emphasis on distributing cash...

In August 2026, Healthpeak Properties, Inc. reported second-quarter revenue of US$771.58 million and net income of US$52.82 million, with diluted earnings per share from continuing operations rising to US$0.08 from US$0.05 a year earlier. For the first half of 2026, the company’s net income increased to US$246.45 million from US$74.50 million, and Healthpeak also raised its full-year diluted earnings guidance to US$0.48–US$0.52 per share, signaling greater confidence in its earnings...

Genius Sports (GENI) is back in focus after reporting second quarter and first half 2026 results, confirming third quarter guidance around US$260 million in revenue and raising its full year 2026 revenue outlook. See our latest analysis for Genius Sports. Genius Sports’ recent guidance update and new data partnerships with Kalshi and Polymarket come as the stock shows strong short term momentum, with a 30 day share price return of 30.73% and a 90 day share price return of 97.64%, even though...

ATI Inc. has already reported second-quarter 2026 results, with sales rising to US$1,261.1 million and net income reaching US$151.0 million, while also completing US$705.12 million of share repurchases totaling 6.57% of its shares under a program begun in 2024. Management highlighted a record US$4.40 billion backlog and margin expansion supported by robust aerospace and defense demand and a higher-value product mix, reinforcing ATI's message that its portfolio transformation is turning the...